CUTANEOUS VASCULITIS DUE TO CYCLOPHOSPHAMIDE THERAPY FOR CHRONIC LYMPHOCYTIC LEUKEMIA
- 1 February 1989
- journal article
- case report
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 19 (1) , 55-57
- https://doi.org/10.1111/j.1445-5994.1989.tb01677.x
Abstract
A 55-year-old male with chronic lymphocytic leukemia developed a skin eruption after receiving oral cyclophosphamide. Subsequent rechallenge with parenteral cyclophosphamide led to recurrence of the skin lesions, which on biopsy were shown to be vasculitic in nature.Keywords
This publication has 6 references indexed in Scilit:
- Cutaneous drug reactions: Pathogenesis and clinical classificationJournal of the American Academy of Dermatology, 1985
- Mechanisms of Action and Clinical Applications of Cytotoxic Drugs in Rheumatic DisordersMedical Clinics of North America, 1985
- Abnormal T-cell subpopulation function in CLL: excessive suppressor (T gamma) and deficient helper (T mu) activity with respect to B-cell proliferationBlood, 1981
- The Spectrum of VasculitisAnnals of Internal Medicine, 1978
- Cyclophosphamide and pigmentation.BMJ, 1972